These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
257 related articles for article (PubMed ID: 30054425)
1. A regulatory circuitry comprising TP53, Chen B; Wang J; Wang J; Wang H; Gu X; Tang L; Feng X Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30054425 [TBL] [Abstract][Full Text] [Related]
2. Suppression of Wnt signaling by the miR-29 family is mediated by demethylation of WIF-1 in non-small-cell lung cancer. Tan M; Wu J; Cai Y Biochem Biophys Res Commun; 2013 Sep; 438(4):673-9. PubMed ID: 23939044 [TBL] [Abstract][Full Text] [Related]
3. MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Fabbri M; Garzon R; Cimmino A; Liu Z; Zanesi N; Callegari E; Liu S; Alder H; Costinean S; Fernandez-Cymering C; Volinia S; Guler G; Morrison CD; Chan KK; Marcucci G; Calin GA; Huebner K; Croce CM Proc Natl Acad Sci U S A; 2007 Oct; 104(40):15805-10. PubMed ID: 17890317 [TBL] [Abstract][Full Text] [Related]
4. DZNep, inhibitor of S-adenosylhomocysteine hydrolase, down-regulates expression of SETDB1 H3K9me3 HMTase in human lung cancer cells. Lee JK; Kim KC Biochem Biophys Res Commun; 2013 Sep; 438(4):647-52. PubMed ID: 23933322 [TBL] [Abstract][Full Text] [Related]
5. A subset of the histone H3 lysine 9 methyltransferases Suv39h1, G9a, GLP, and SETDB1 participate in a multimeric complex. Fritsch L; Robin P; Mathieu JR; Souidi M; Hinaux H; Rougeulle C; Harel-Bellan A; Ameyar-Zazoua M; Ait-Si-Ali S Mol Cell; 2010 Jan; 37(1):46-56. PubMed ID: 20129054 [TBL] [Abstract][Full Text] [Related]
6. MiR-29c reduces the cisplatin resistance of non-small cell lung cancer cells by negatively regulating the PI3K/Akt pathway. Sun DM; Tang BF; Li ZX; Guo HB; Cheng JL; Song PP; Zhao X Sci Rep; 2018 May; 8(1):8007. PubMed ID: 29789623 [TBL] [Abstract][Full Text] [Related]
7. Ubiquitination of Lysine 867 of the Human SETDB1 Protein Upregulates Its Histone H3 Lysine 9 (H3K9) Methyltransferase Activity. Ishimoto K; Kawamata N; Uchihara Y; Okubo M; Fujimoto R; Gotoh E; Kakinouchi K; Mizohata E; Hino N; Okada Y; Mochizuki Y; Tanaka T; Hamakubo T; Sakai J; Kodama T; Inoue T; Tachibana K; Doi T PLoS One; 2016; 11(10):e0165766. PubMed ID: 27798683 [TBL] [Abstract][Full Text] [Related]
8. Up-regulation of histone methyltransferase SETDB1 by multiple mechanisms in hepatocellular carcinoma promotes cancer metastasis. Wong CM; Wei L; Law CT; Ho DW; Tsang FH; Au SL; Sze KM; Lee JM; Wong CC; Ng IO Hepatology; 2016 Feb; 63(2):474-87. PubMed ID: 26481868 [TBL] [Abstract][Full Text] [Related]
9. Histone methyltransferase SETDB1 regulates liver cancer cell growth through methylation of p53. Fei Q; Shang K; Zhang J; Chuai S; Kong D; Zhou T; Fu S; Liang Y; Li C; Chen Z; Zhao Y; Yu Z; Huang Z; Hu M; Ying H; Chen Z; Zhang Y; Xing F; Zhu J; Xu H; Zhao K; Lu C; Atadja P; Xiao ZX; Li E; Shou J Nat Commun; 2015 Oct; 6():8651. PubMed ID: 26471002 [TBL] [Abstract][Full Text] [Related]
10. Smad3-mediated recruitment of the methyltransferase SETDB1/ESET controls Du D; Katsuno Y; Meyer D; Budi EH; Chen SH; Koeppen H; Wang H; Akhurst RJ; Derynck R EMBO Rep; 2018 Jan; 19(1):135-155. PubMed ID: 29233829 [TBL] [Abstract][Full Text] [Related]
11. Evidence that miR-152-3p is a positive regulator of SETDB1-mediated H3K9 histone methylation and serves as a toggle between histone and DNA methylation. Singh SK; Bahal R; Rasmussen TP Exp Cell Res; 2020 Oct; 395(2):112216. PubMed ID: 32768498 [TBL] [Abstract][Full Text] [Related]
13. Jarid2 (Jumonji, AT rich interactive domain 2) regulates NOTCH1 expression via histone modification in the developing heart. Mysliwiec MR; Carlson CD; Tietjen J; Hung H; Ansari AZ; Lee Y J Biol Chem; 2012 Jan; 287(2):1235-41. PubMed ID: 22110129 [TBL] [Abstract][Full Text] [Related]
14. SETDB1 accelerates tumourigenesis by regulating the WNT signalling pathway. Sun QY; Ding LW; Xiao JF; Chien W; Lim SL; Hattori N; Goodglick L; Chia D; Mah V; Alavi M; Kim SR; Doan NB; Said JW; Loh XY; Xu L; Liu LZ; Yang H; Hayano T; Shi S; Xie D; Lin DC; Koeffler HP J Pathol; 2015 Mar; 235(4):559-70. PubMed ID: 25404354 [TBL] [Abstract][Full Text] [Related]
15. p53 down-regulates SETDB1 gene expression during paclitaxel induced-cell death. Noh HJ; Kim KA; Kim KC Biochem Biophys Res Commun; 2014 Mar; 446(1):43-8. PubMed ID: 24565839 [TBL] [Abstract][Full Text] [Related]
16. Trimethylation of histone H3 lysine 4 impairs methylation of histone H3 lysine 9: regulation of lysine methyltransferases by physical interaction with their substrates. Binda O; LeRoy G; Bua DJ; Garcia BA; Gozani O; Richard S Epigenetics; 2010; 5(8):767-75. PubMed ID: 21124070 [TBL] [Abstract][Full Text] [Related]
17. The mechanism involved in the loss of PTEN expression in NSCLC tumor cells. Li G; Zhao J; Peng X; Liang J; Deng X; Chen Y Biochem Biophys Res Commun; 2012 Feb; 418(3):547-52. PubMed ID: 22290228 [TBL] [Abstract][Full Text] [Related]
18. Upregulation of miR-675-5p induced by lncRNA H19 was associated with tumor progression and development by targeting tumor suppressor p53 in non-small cell lung cancer. Zheng ZH; Wu DM; Fan SH; Zhang ZF; Chen GQ; Lu J J Cell Biochem; 2019 Nov; 120(11):18724-18735. PubMed ID: 31219199 [TBL] [Abstract][Full Text] [Related]
19. MiR-542-3p exerts tumor suppressive functions in non-small cell lung cancer cells by upregulating FTSJ2. Liu B; Li J; Zheng M; Ge J; Li J; Yu P Life Sci; 2017 Nov; 188():87-95. PubMed ID: 28866101 [TBL] [Abstract][Full Text] [Related]
20. MicroRNA-374b mediates the initiation of non-small cell lung cancer by regulating ITGB1 and p53 expressions. Zhao M; Tong C; Hao Z; Zhao R; Wang L Thorac Cancer; 2020 Jun; 11(6):1670-1678. PubMed ID: 32364676 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]